Sale!

Bordetella Multiplex Detection & Differentiation RNA Detection Qualitative Test

Original price was: $350.Current price is: $298.

-15%

The Bordetella Multiplex RNA Detection Qualitative Test is an advanced molecular diagnostic tool that simultaneously detects and differentiates three significant respiratory pathogens: Bordetella pertussis (whooping cough), Legionella pneumophilia (Legionnaires’ disease), and Klebsiella pneumonia. Using cutting-edge Real-Time PCR technology, this test provides rapid and highly accurate results within 36-48 hours. It’s particularly valuable for patients presenting with persistent cough, fever, respiratory distress, or pneumonia-like symptoms. The test costs $298 USD and offers comprehensive pathogen identification to guide appropriate treatment decisions, helping healthcare providers distinguish between these clinically similar respiratory infections that require different therapeutic approaches.

Clinically Validated & Lab Certified

  • ISO-Accredited Laboratory, Ensuring Highest Standards
  • Trusted by Hospitals & Patients —Accredited Testing with Results
  • Direct Healthcare Provider Support + Comprehensive Reporting
Guaranteed Safe Checkout

Bordetella Multiplex Detection & Differentiation RNA Detection Qualitative Test

Comprehensive Respiratory Pathogen Detection

The Bordetella Multiplex RNA Detection Qualitative Test represents a significant advancement in respiratory infection diagnostics. This sophisticated molecular test utilizes Real-Time PCR technology to simultaneously identify and differentiate three clinically important respiratory pathogens that often present with similar symptoms but require distinct treatment approaches. By detecting the specific RNA of these microorganisms, the test provides healthcare providers with precise diagnostic information to guide appropriate therapeutic interventions.

What This Test Measures and Detects

This multiplex assay specifically targets and identifies:

  • Bordetella pertussis – The causative agent of whooping cough, characterized by severe paroxysmal coughing
  • Legionella pneumophilia – Responsible for Legionnaires’ disease, a severe form of pneumonia
  • Klebsiella pneumonia – A common hospital-acquired pneumonia pathogen with increasing antibiotic resistance

The test employs qualitative RNA detection methodology, providing definitive presence/absence results for each pathogen with exceptional sensitivity and specificity exceeding 98%.

Who Should Consider This Test

This comprehensive respiratory panel is particularly recommended for individuals experiencing:

  • Persistent cough lasting more than 2 weeks
  • Severe coughing fits with whooping sounds or post-tussive vomiting
  • High fever accompanied by respiratory symptoms
  • Community-acquired or hospital-acquired pneumonia
  • Respiratory distress requiring hospitalization
  • Immunocompromised patients with respiratory infections
  • Individuals with exposure to confirmed cases of whooping cough or Legionnaires’ disease
  • Patients not responding to initial antibiotic therapy

Clinical Benefits of Multiplex Respiratory Testing

Choosing the Bordetella Multiplex RNA Detection Test offers numerous advantages:

  • Rapid Diagnosis: Results available within 36-48 hours compared to traditional culture methods
  • Comprehensive Coverage: Simultaneous detection of three major respiratory pathogens
  • Treatment Guidance: Enables targeted antibiotic therapy based on specific pathogen identification
  • Infection Control: Facilitates appropriate isolation and prevention measures
  • Public Health Impact: Early detection helps prevent outbreaks in community and healthcare settings
  • Cost-Effective: Single test replaces multiple individual pathogen tests

Understanding Your Test Results

Your test report will clearly indicate the presence or absence of each targeted pathogen:

  • Positive for Bordetella pertussis: Indicates active whooping cough infection requiring specific antibiotic treatment and respiratory isolation
  • Positive for Legionella pneumophilia: Confirms Legionnaires’ disease, necessitating specialized antibiotic therapy
  • Positive for Klebsiella pneumonia: Identifies this antibiotic-resistant pathogen, guiding appropriate antimicrobial selection
  • Negative Results: All three pathogens not detected, suggesting alternative causes for respiratory symptoms

All results should be interpreted by your healthcare provider in the context of your clinical presentation and medical history.

Test Information and Pricing

Test Parameter Details
Test Name Bordetella Multiplex Detection & Differentiation RNA Detection Qualitative Test
Regular Price $350 USD
Discount Price $298 USD
Turnaround Time 4th Working Day Email: 48 hours | On Phone: 36 hours
Sample Type Nasopharyngeal secretions, swabs, Oral/rectal swabs, necropsy samples, Blood, Urine, Sputum, throat swab, bronchoalveolar lavage samples, lung tissue
Methodology Real-Time PCR

Pre-Test Instructions

To ensure accurate results, please bring the following to your appointment:

  • Signed consent document for Bordetella Multiplex Detection & Differentiation Test
  • Complete clinical history of the patient
  • Any relevant medical records or previous test results
  • Current medication list

Nationwide Availability

We have diagnostic centers conveniently located across the United States, including major metropolitan areas such as New York, Los Angeles, Chicago, Houston, Phoenix, Philadelphia, San Antonio, San Diego, Dallas, San Jose, and many other cities. Our state-of-the-art facilities ensure consistent, high-quality testing services nationwide.

Take Action for Your Respiratory Health

Don’t let persistent respiratory symptoms go undiagnosed. Early detection of these serious respiratory pathogens can significantly impact treatment outcomes and prevent complications. Our expert team is ready to provide you with accurate, timely results to guide your healthcare journey.

Call or WhatsApp us today at +1(267) 388-9828 to schedule your Bordetella Multiplex RNA Detection Test and take the first step toward precise respiratory infection diagnosis and effective treatment.